Biogen Immunology Strategy Comes Into Focus With $1B HI-Bio Acquisition medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.
Biogen Stock Continues Its 20% Sprint On An Alzheimer's Treatment Twist investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.
Eisai predicts sharp Leqembi sales increase as launch efforts begin to bear fruit fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.
Moderna Stock Seesaws After The FDA Throws A Curveball On Its RSV Vaccine investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.
Moderna Says FDA Delaying Decision on RSV Vaccine Approval bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
Moderna says FDA delaying decision on RSV vaccine approval phillytrib.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phillytrib.com Daily Mail and Mail on Sunday newspapers.
Neurocrine Biosciences Is Making Good On Its Ingrezza Diversification, And Its Biotech Stock Is Flying investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.
Moderna gears up for potential RSV vaccine launch this fall after better-than-expected first quarter fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.